Adage Capital Partners Gp, L.L.C. Neogenomics Inc Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $2.2 Million - $3.24 Million	-181,380 Reduced 90.69%	18,620 $229,000
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $1.41 Million - $1.98 Million	-100,000 Reduced 33.33%	200,000 $3.21 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $2.73 Million - $5.84 Million	300,000 New	300,000 $5.22 Million

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.